MORAb-028

human IgM monoclonal antibody · Morphotek

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MORAb-028, covering 2014-07-16 to 2014-07-17. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of Human IgM (MORAb-028) to Treat Metastatic Melanoma [Phase 1]